| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | SOX6 ZNF93 ZNF765 ZNF627 ZNF586 ZEB1 ZNF555 TRPS1 ZNF485 ZNF429 ZFP28 ZNF491 ZNF440 ZNF77 ZNF557 ZNF512B ZNF7 ZSCAN32 ZNF550 ZNF530 ZNF256 ZNF347 ZNF558 ZNF737 ZNF841 ZNF679 ZBTB3 ST18 ZNF583 ZNF669 | 1.78e-08 | 1412 | 136 | 30 | GO:0000981 |
| GeneOntologyMolecularFunction | olfactory receptor activity | OR8K1 OR9A4 OR9G1 OR4C6 OR8S1 OR5AK3P OR5A2 OR6F1 OR6A2 OR10K1 OR5K1 OR5H1 OR7G3 OR51B2 OR5AP2 OR9A2 | 4.12e-08 | 431 | 136 | 16 | GO:0004984 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | SOX6 ZNF93 ZNF765 ZNF627 ZNF586 ZEB1 ZNF555 TRPS1 ZNF485 ZNF429 ZFP28 ZNF491 ZNF440 ZNF77 ZNF557 ZNF512B ZNF7 ZSCAN32 ZNF550 ZNF530 ZNF256 ZNF347 ZNF558 ZNF737 ZNF841 ZNF679 ST18 ZNF583 ZNF669 | 1.36e-07 | 1459 | 136 | 29 | GO:0000977 |
| GeneOntologyMolecularFunction | granulocyte colony-stimulating factor receptor binding | 1.95e-06 | 14 | 136 | 4 | GO:0005130 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR8K1 CCR10 OR9A4 OR9G1 OR4C6 GPR39 OR8S1 OR5AK3P OR5A2 OPRM1 OR6F1 OR6A2 OR10K1 CCR5 OR5K1 OR5H1 OR7G3 OR51B2 OR5AP2 OR9A2 | 2.32e-06 | 884 | 136 | 20 | GO:0004930 |
| GeneOntologyMolecularFunction | odorant binding | 2.56e-06 | 127 | 136 | 8 | GO:0005549 | |
| GeneOntologyMolecularFunction | bile acid transmembrane transporter activity | 3.23e-06 | 34 | 136 | 5 | GO:0015125 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | OR8K1 CCR10 FLT3 OR9A4 OR9G1 OR4C6 GPR39 OR8S1 OR5AK3P GRIA4 OR5A2 PLXNB2 OPRM1 OR6F1 OR6A2 IGF2R PTPRF OR10K1 CCR5 OR5K1 OR5H1 OR7G3 OR51B2 OR5AP2 OR9A2 | 4.31e-06 | 1353 | 136 | 25 | GO:0004888 |
| GeneOntologyMolecularFunction | GPI anchor binding | 1.65e-05 | 23 | 136 | 4 | GO:0034235 | |
| GeneOntologyMolecularFunction | filamin binding | 4.28e-05 | 29 | 136 | 4 | GO:0031005 | |
| GeneOntologyMolecularFunction | Toll-like receptor binding | 4.28e-05 | 29 | 136 | 4 | GO:0035325 | |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 1.16e-04 | 70 | 136 | 5 | GO:1901618 | |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 1.41e-04 | 73 | 136 | 5 | GO:0170055 | |
| GeneOntologyMolecularFunction | glycolipid binding | 3.44e-04 | 49 | 136 | 4 | GO:0051861 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 3.76e-04 | 90 | 136 | 5 | GO:0008028 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 3.96e-04 | 196 | 136 | 7 | GO:0005319 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase binding | 5.53e-04 | 149 | 136 | 6 | GO:1990782 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | SOX6 ZNF93 ZNF765 ZNF586 ZEB1 ZNF485 ZNF429 ZFP28 ZNF7 ZSCAN32 ZNF530 ZNF256 ZNF347 ZNF737 ZNF841 ZNF679 ST18 ZNF583 | 1.97e-03 | 1244 | 136 | 18 | GO:0000978 |
| GeneOntologyMolecularFunction | phosphatase binding | 2.24e-03 | 264 | 136 | 7 | GO:0019902 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | SOX6 ZNF93 ZNF765 ZNF586 ZEB1 ZNF485 ZNF429 ZFP28 ZNF7 ZSCAN32 ZNF530 ZNF256 ZNF347 ZNF737 ZNF841 ZNF679 ST18 ZNF583 | 2.49e-03 | 1271 | 136 | 18 | GO:0000987 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | OR8K1 OR9A4 OR9G1 OR4C6 OR8S1 OR5AK3P OR5A2 OR6F1 OR6A2 OR10K1 OR5K1 OR5H1 OR7G3 OR51B2 OR5AP2 OR9A2 | 2.46e-08 | 432 | 135 | 16 | GO:0050911 |
| GeneOntologyBiologicalProcess | sensory perception of smell | OR8K1 OR9A4 OR9G1 OR4C6 OR8S1 OR5AK3P OR5A2 OR6F1 OR6A2 OR10K1 OR5K1 OR5H1 OR7G3 OR51B2 OR5AP2 OR9A2 | 6.80e-08 | 465 | 135 | 16 | GO:0007608 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | OR8K1 OR9A4 OR9G1 OR4C6 OR8S1 OR5AK3P OR5A2 OR6F1 OR6A2 OR10K1 OR5K1 OR5H1 OR7G3 OR51B2 OR5AP2 OR9A2 | 1.21e-07 | 485 | 135 | 16 | GO:0050907 |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | OR8K1 OR9A4 OR9G1 OR4C6 OR8S1 OR5AK3P OR5A2 OR6F1 OR6A2 EYS OR10K1 OR5K1 OR5H1 OR7G3 OR51B2 OR5AP2 OR9A2 | 2.67e-07 | 582 | 135 | 17 | GO:0050906 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | OR8K1 OR9A4 OR9G1 OR4C6 OR8S1 OR5AK3P OR5A2 OR6F1 OR6A2 OR10K1 OR5K1 OR5H1 OR7G3 OR51B2 OR5AP2 OR9A2 | 3.42e-07 | 524 | 135 | 16 | GO:0009593 |
| GeneOntologyBiologicalProcess | common myeloid progenitor cell proliferation | 5.33e-07 | 25 | 135 | 5 | GO:0035726 | |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | OR8K1 OR9A4 OR9G1 OR4C6 OR8S1 OR5AK3P OR5A2 OR6F1 OR6A2 OR10K1 OR5K1 OR5H1 OR7G3 OR51B2 OR5AP2 OR9A2 | 6.05e-07 | 547 | 135 | 16 | GO:0007606 |
| GeneOntologyBiologicalProcess | negative regulation of brown fat cell proliferation | 1.67e-06 | 14 | 135 | 4 | GO:0070348 | |
| GeneOntologyBiologicalProcess | regulation of brown fat cell proliferation | 2.27e-06 | 15 | 135 | 4 | GO:0070347 | |
| GeneOntologyBiologicalProcess | positive regulation of homophilic cell adhesion | 2.27e-06 | 15 | 135 | 4 | GO:1903387 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immune response to tumor cell | 2.27e-06 | 15 | 135 | 4 | GO:0002856 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 2.27e-06 | 15 | 135 | 4 | GO:0002859 | |
| GeneOntologyBiologicalProcess | insulin receptor internalization | 3.01e-06 | 16 | 135 | 4 | GO:0038016 | |
| GeneOntologyBiologicalProcess | brown fat cell proliferation | 3.91e-06 | 17 | 135 | 4 | GO:0070342 | |
| GeneOntologyBiologicalProcess | insulin catabolic process | 3.91e-06 | 17 | 135 | 4 | GO:1901143 | |
| GeneOntologyBiologicalProcess | granulocyte colony-stimulating factor signaling pathway | 3.91e-06 | 17 | 135 | 4 | GO:0038158 | |
| GeneOntologyBiologicalProcess | regulation of homophilic cell adhesion | 5.00e-06 | 18 | 135 | 4 | GO:1903385 | |
| GeneOntologyBiologicalProcess | detection of stimulus | OR8K1 OR9A4 OR9G1 OR4C6 OR8S1 OR5AK3P OR5A2 OR6F1 OR6A2 EYS OR10K1 OR5K1 OR5H1 OR7G3 OR51B2 OR5AP2 OR9A2 | 5.05e-06 | 722 | 135 | 17 | GO:0051606 |
| GeneOntologyBiologicalProcess | regulation of endothelial cell differentiation | 5.06e-06 | 67 | 135 | 6 | GO:0045601 | |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid biosynthetic process | 5.37e-06 | 39 | 135 | 5 | GO:0045717 | |
| GeneOntologyBiologicalProcess | sensory perception | OR8K1 OR9A4 OR9G1 OR4C6 OR8S1 OR5AK3P OR5A2 OPRM1 OR6F1 OR6A2 EYS OTOF OR10K1 OR5K1 OR5H1 OR7G3 ANKFN1 OR51B2 OR5AP2 OR9A2 OTOG | 6.40e-06 | 1072 | 135 | 21 | GO:0007600 |
| GeneOntologyBiologicalProcess | negative regulation of hepatocyte proliferation | 7.84e-06 | 20 | 135 | 4 | GO:2000346 | |
| GeneOntologyBiologicalProcess | negative regulation of fat cell proliferation | 9.63e-06 | 21 | 135 | 4 | GO:0070345 | |
| GeneOntologyBiologicalProcess | negative regulation of response to tumor cell | 9.63e-06 | 21 | 135 | 4 | GO:0002835 | |
| GeneOntologyBiologicalProcess | negative regulation of immune response to tumor cell | 9.63e-06 | 21 | 135 | 4 | GO:0002838 | |
| GeneOntologyBiologicalProcess | negative regulation of granulocyte differentiation | 1.17e-05 | 22 | 135 | 4 | GO:0030853 | |
| GeneOntologyBiologicalProcess | bile acid and bile salt transport | 1.37e-05 | 47 | 135 | 5 | GO:0015721 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet aggregation | 1.41e-05 | 23 | 135 | 4 | GO:0090331 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 1.41e-05 | 23 | 135 | 4 | GO:0002858 | |
| GeneOntologyBiologicalProcess | positive regulation of vasculogenesis | 1.68e-05 | 24 | 135 | 4 | GO:2001214 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immune response to tumor cell | 1.68e-05 | 24 | 135 | 4 | GO:0002855 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity directed against tumor cell target | 1.68e-05 | 24 | 135 | 4 | GO:0002420 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated immune response to tumor cell | 2.00e-05 | 25 | 135 | 4 | GO:0002423 | |
| GeneOntologyBiologicalProcess | positive regulation of MAP kinase activity | 2.27e-05 | 129 | 135 | 7 | GO:0043406 | |
| GeneOntologyBiologicalProcess | regulation of fat cell proliferation | 2.74e-05 | 27 | 135 | 4 | GO:0070344 | |
| GeneOntologyBiologicalProcess | negative regulation of lipid biosynthetic process | 2.97e-05 | 91 | 135 | 6 | GO:0051055 | |
| GeneOntologyBiologicalProcess | negative regulation of homotypic cell-cell adhesion | 3.18e-05 | 28 | 135 | 4 | GO:0034111 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | OR8K1 CCR10 PDE3B OR9A4 OR9G1 OR4C6 GPR39 OR8S1 OR5AK3P OR5A2 OPRM1 OR6F1 OR6A2 IGF2R PLPP1 OR10K1 CCR5 OR5K1 OR5H1 OR7G3 OR51B2 OR5AP2 OR9A2 | 3.57e-05 | 1395 | 135 | 23 | GO:0007186 |
| GeneOntologyBiologicalProcess | regulation of vasculogenesis | 3.67e-05 | 29 | 135 | 4 | GO:2001212 | |
| GeneOntologyBiologicalProcess | regulation of MAP kinase activity | 4.24e-05 | 194 | 135 | 8 | GO:0043405 | |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid metabolic process | 4.56e-05 | 60 | 135 | 5 | GO:0045922 | |
| GeneOntologyBiologicalProcess | negative regulation of lipid metabolic process | 4.80e-05 | 145 | 135 | 7 | GO:0045833 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet activation | 4.81e-05 | 31 | 135 | 4 | GO:0010544 | |
| GeneOntologyBiologicalProcess | negative regulation of bone resorption | 5.47e-05 | 32 | 135 | 4 | GO:0045779 | |
| GeneOntologyBiologicalProcess | fat cell proliferation | 5.47e-05 | 32 | 135 | 4 | GO:0070341 | |
| GeneOntologyBiologicalProcess | regulation of blood vessel remodeling | 5.47e-05 | 32 | 135 | 4 | GO:0060312 | |
| GeneOntologyBiologicalProcess | regulation of granulocyte differentiation | 6.20e-05 | 33 | 135 | 4 | GO:0030852 | |
| GeneOntologyBiologicalProcess | negative regulation of feeding behavior | 6.20e-05 | 33 | 135 | 4 | GO:2000252 | |
| GeneOntologyBiologicalProcess | negative regulation of vascular permeability | 6.99e-05 | 34 | 135 | 4 | GO:0043116 | |
| GeneOntologyBiologicalProcess | negative regulation of bone remodeling | 6.99e-05 | 34 | 135 | 4 | GO:0046851 | |
| GeneOntologyBiologicalProcess | regulation of platelet activation | 7.23e-05 | 66 | 135 | 5 | GO:0010543 | |
| GeneOntologyBiologicalProcess | insulin metabolic process | 7.85e-05 | 35 | 135 | 4 | GO:1901142 | |
| GeneOntologyBiologicalProcess | negative regulation of blood coagulation | 8.96e-05 | 69 | 135 | 5 | GO:0030195 | |
| GeneOntologyBiologicalProcess | negative regulation of hemostasis | 9.59e-05 | 70 | 135 | 5 | GO:1900047 | |
| GeneOntologyBiologicalProcess | regulation of hepatocyte proliferation | 1.09e-04 | 38 | 135 | 4 | GO:2000345 | |
| GeneOntologyBiologicalProcess | negative regulation of coagulation | 1.10e-04 | 72 | 135 | 5 | GO:0050819 | |
| GeneOntologyBiologicalProcess | negative regulation of interleukin-1 production | 1.10e-04 | 72 | 135 | 5 | GO:0032692 | |
| GeneOntologyBiologicalProcess | regulation of fatty acid biosynthetic process | 1.17e-04 | 73 | 135 | 5 | GO:0042304 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity | 1.34e-04 | 40 | 135 | 4 | GO:0045953 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immunity | 1.47e-04 | 41 | 135 | 4 | GO:0002716 | |
| GeneOntologyBiologicalProcess | regulation of platelet aggregation | 1.62e-04 | 42 | 135 | 4 | GO:0090330 | |
| GeneOntologyBiologicalProcess | negative regulation of behavior | 2.12e-04 | 45 | 135 | 4 | GO:0048521 | |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte mediated immunity | 2.15e-04 | 83 | 135 | 5 | GO:0002707 | |
| GeneOntologyBiologicalProcess | epithelial cell proliferation involved in liver morphogenesis | 2.31e-04 | 46 | 135 | 4 | GO:0072575 | |
| GeneOntologyBiologicalProcess | hepatocyte proliferation | 2.31e-04 | 46 | 135 | 4 | GO:0072574 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated cytotoxicity | 2.52e-04 | 47 | 135 | 4 | GO:0001911 | |
| GeneOntologyBiologicalProcess | negative regulation of tissue remodeling | 2.52e-04 | 47 | 135 | 4 | GO:0034104 | |
| GeneOntologyBiologicalProcess | regulation of epidermal growth factor receptor signaling pathway | 2.54e-04 | 86 | 135 | 5 | GO:0042058 | |
| GeneOntologyBiologicalProcess | positive regulation of protein serine/threonine kinase activity | 2.84e-04 | 193 | 135 | 7 | GO:0071902 | |
| GeneOntologyBiologicalProcess | liver morphogenesis | 2.96e-04 | 49 | 135 | 4 | GO:0072576 | |
| GeneOntologyBiologicalProcess | regulation of immune response to tumor cell | 2.96e-04 | 49 | 135 | 4 | GO:0002837 | |
| GeneOntologyBiologicalProcess | regulation of response to tumor cell | 3.20e-04 | 50 | 135 | 4 | GO:0002834 | |
| GeneOntologyBiologicalProcess | regulation of blood coagulation | 3.30e-04 | 91 | 135 | 5 | GO:0030193 | |
| GeneOntologyBiologicalProcess | regulation of ERBB signaling pathway | 3.65e-04 | 93 | 135 | 5 | GO:1901184 | |
| GeneOntologyBiologicalProcess | regulation of hemostasis | 3.65e-04 | 93 | 135 | 5 | GO:1900046 | |
| GeneOntologyBiologicalProcess | negative regulation of cell killing | 3.72e-04 | 52 | 135 | 4 | GO:0031342 | |
| GeneOntologyBiologicalProcess | regulation of homotypic cell-cell adhesion | 4.01e-04 | 53 | 135 | 4 | GO:0034110 | |
| GeneOntologyBiologicalProcess | regulation of lipid metabolic process | 4.12e-04 | 415 | 135 | 10 | GO:0019216 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated immunity | 4.23e-04 | 96 | 135 | 5 | GO:0002704 | |
| GeneOntologyBiologicalProcess | regulation of coagulation | 4.23e-04 | 96 | 135 | 5 | GO:0050818 | |
| GeneOntologyBiologicalProcess | negative regulation of wound healing | 4.65e-04 | 98 | 135 | 5 | GO:0061045 | |
| GeneOntologyBiologicalProcess | immune response to tumor cell | 4.95e-04 | 56 | 135 | 4 | GO:0002418 | |
| GeneOntologyBiologicalProcess | negative regulation of osteoclast differentiation | 6.04e-04 | 59 | 135 | 4 | GO:0045671 | |
| GeneOntologyBiologicalProcess | endothelial cell differentiation | 6.12e-04 | 158 | 135 | 6 | GO:0045446 | |
| GeneOntologyBiologicalProcess | granulocyte differentiation | 6.44e-04 | 60 | 135 | 4 | GO:0030851 | |
| GeneOntologyBiologicalProcess | regulation of feeding behavior | 6.86e-04 | 61 | 135 | 4 | GO:0060259 | |
| GeneOntologyBiologicalProcess | feeding behavior | 6.98e-04 | 162 | 135 | 6 | GO:0007631 | |
| GeneOntologyBiologicalProcess | regulation of interleukin-1 production | 7.68e-04 | 165 | 135 | 6 | GO:0032652 | |
| GeneOntologyBiologicalProcess | interleukin-1 production | 9.25e-04 | 171 | 135 | 6 | GO:0032612 | |
| GeneOntologyBiologicalProcess | regulation of bone resorption | 1.15e-03 | 70 | 135 | 4 | GO:0045124 | |
| GeneOntologyBiologicalProcess | regulation of lipid biosynthetic process | 1.20e-03 | 246 | 135 | 7 | GO:0046890 | |
| GeneOntologyBiologicalProcess | regulation of vascular permeability | 1.21e-03 | 71 | 135 | 4 | GO:0043114 | |
| GeneOntologyBiologicalProcess | response to tumor cell | 1.21e-03 | 71 | 135 | 4 | GO:0002347 | |
| GeneOntologyBiologicalProcess | endothelium development | 1.28e-03 | 182 | 135 | 6 | GO:0003158 | |
| GeneOntologyBiologicalProcess | negative regulation of response to wounding | 1.45e-03 | 126 | 135 | 5 | GO:1903035 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | 1.46e-03 | 187 | 135 | 6 | GO:0007156 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity | 1.56e-03 | 76 | 135 | 4 | GO:0042269 | |
| GeneOntologyBiologicalProcess | fatty acid biosynthetic process | 1.63e-03 | 191 | 135 | 6 | GO:0006633 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immunity | 1.89e-03 | 80 | 135 | 4 | GO:0002715 | |
| GeneOntologyBiologicalProcess | regulation of bone remodeling | 1.89e-03 | 80 | 135 | 4 | GO:0046850 | |
| GeneOntologyCellularComponent | transforming growth factor beta ligand-receptor complex | 3.02e-06 | 16 | 137 | 4 | GO:0070021 | |
| MousePheno | abnormal susceptibility to Coronaviridae infection | 4.79e-07 | 49 | 85 | 6 | MP:0020948 | |
| MousePheno | decreased susceptibility to Coronaviridae infection | 6.50e-07 | 28 | 85 | 5 | MP:0020950 | |
| MousePheno | increased insulin secretion | 2.39e-06 | 64 | 85 | 6 | MP:0003058 | |
| MousePheno | decreased susceptibility to Coronaviridae infection induced morbidity/mortality | 2.85e-06 | 17 | 85 | 4 | MP:0031047 | |
| MousePheno | decreased susceptibility to Riboviria infection induced morbidity/mortality | 6.65e-06 | 44 | 85 | 5 | MP:0031023 | |
| MousePheno | increased skeletal muscle triglyceride level | 7.04e-06 | 21 | 85 | 4 | MP:0031415 | |
| MousePheno | increased total tissue mass | PDE3B ZEB1 PSG1 PSG3 PSG4 GPR39 PLXNB2 OPRM1 IGF2R DCLRE1C PSG8 | 1.22e-05 | 364 | 85 | 11 | MP:0012323 |
| MousePheno | increased body weight | PDE3B ZEB1 PSG1 PSG3 PSG4 GPR39 PLXNB2 OPRM1 IGF2R DCLRE1C PSG8 | 1.22e-05 | 364 | 85 | 11 | MP:0001260 |
| MousePheno | decreased fatty acid oxidation | 1.23e-05 | 24 | 85 | 4 | MP:0014172 | |
| MousePheno | increased abdominal fat pad weight | 2.01e-05 | 27 | 85 | 4 | MP:0009286 | |
| MousePheno | decreased susceptibility to viral infection induced morbidity/mortality | 3.10e-05 | 60 | 85 | 5 | MP:0009790 | |
| MousePheno | abnormal skeletal muscle triglyceride level | 3.53e-05 | 31 | 85 | 4 | MP:0031413 | |
| MousePheno | decreased carbon dioxide production | 3.53e-05 | 31 | 85 | 4 | MP:0008964 | |
| MousePheno | increased body size | PDE3B ZEB1 PSG1 PSG3 PSG4 GPR39 PLXNB2 OPRM1 IGF2R DCLRE1C PSG8 | 3.58e-05 | 409 | 85 | 11 | MP:0001264 |
| MousePheno | decreased skeletal muscle cell glucose uptake | 5.77e-05 | 35 | 85 | 4 | MP:0031618 | |
| MousePheno | abnormal muscle triglyceride level | 6.47e-05 | 36 | 85 | 4 | MP:0031412 | |
| MousePheno | abnormal vascular wound healing | 8.01e-05 | 73 | 85 | 5 | MP:0004883 | |
| MousePheno | abnormal insulin secretion | 8.02e-05 | 171 | 85 | 7 | MP:0003564 | |
| MousePheno | decreased muscle cell glucose uptake | 8.90e-05 | 39 | 85 | 4 | MP:0030022 | |
| MousePheno | abnormal endocrine pancreas secretion | 9.62e-05 | 176 | 85 | 7 | MP:0014195 | |
| MousePheno | mandibular condyloid process hypoplasia | 1.09e-04 | 3 | 85 | 2 | MP:0030259 | |
| MousePheno | decreased susceptibility to viral infection | 1.11e-04 | 125 | 85 | 6 | MP:0002410 | |
| MousePheno | decreased oxygen consumption | 1.17e-04 | 79 | 85 | 5 | MP:0005290 | |
| MousePheno | abnormal pancreas secretion | 1.23e-04 | 183 | 85 | 7 | MP:0002694 | |
| MousePheno | abnormal susceptibility to Riboviria infection | 1.36e-04 | 186 | 85 | 7 | MP:0020912 | |
| MousePheno | decreased susceptibility to Riboviria infection | 1.39e-04 | 82 | 85 | 5 | MP:0020914 | |
| MousePheno | abnormal skeletal muscle cell glucose uptake | 1.86e-04 | 47 | 85 | 4 | MP:0031617 | |
| MousePheno | abnormal pancreatic beta cell physiology | 1.88e-04 | 196 | 85 | 7 | MP:0003562 | |
| MousePheno | mandibular coronoid process hypoplasia | 2.18e-04 | 4 | 85 | 2 | MP:0030285 | |
| MousePheno | abnormal endocrine pancreas physiology | 2.26e-04 | 202 | 85 | 7 | MP:0010147 | |
| MousePheno | decreased interleukin-1 beta secretion | 2.97e-04 | 53 | 85 | 4 | MP:0008658 | |
| MousePheno | decreased cellular glucose uptake | 2.97e-04 | 53 | 85 | 4 | MP:0003926 | |
| MousePheno | abnormal fatty acid oxidation | 3.19e-04 | 54 | 85 | 4 | MP:0010953 | |
| MousePheno | abnormal endocrine gland physiology | 3.52e-04 | 363 | 85 | 9 | MP:0013561 | |
| MousePheno | multi-headed sperm | 3.61e-04 | 5 | 85 | 2 | MP:0031408 | |
| MousePheno | abnormal interleukin-1 beta secretion | 3.70e-04 | 101 | 85 | 5 | MP:0008656 | |
| MousePheno | respiratory failure | 5.00e-04 | 165 | 85 | 6 | MP:0001953 | |
| MousePheno | abnormal lipid oxidation | 5.10e-04 | 61 | 85 | 4 | MP:0010951 | |
| MousePheno | abnormal interleukin-1 secretion | 5.25e-04 | 109 | 85 | 5 | MP:0008650 | |
| MousePheno | small lymph nodes | 5.77e-04 | 63 | 85 | 4 | MP:0002217 | |
| MousePheno | decreased respiration | 5.86e-04 | 170 | 85 | 6 | MP:0014274 | |
| MousePheno | obese | 6.19e-04 | 113 | 85 | 5 | MP:0001261 | |
| MousePheno | maternal imprinting | 6.37e-04 | 28 | 85 | 3 | MP:0003122 | |
| MousePheno | decreased splenocyte number | 6.37e-04 | 28 | 85 | 3 | MP:0009339 | |
| MousePheno | short sternum | 7.07e-04 | 29 | 85 | 3 | MP:0004321 | |
| MousePheno | abnormal muscle cell glucose uptake | 7.29e-04 | 67 | 85 | 4 | MP:0004130 | |
| MousePheno | abnormal carbon dioxide production | 7.29e-04 | 67 | 85 | 4 | MP:0008962 | |
| MousePheno | decreased susceptibility to infection induced morbidity/mortality | 8.14e-04 | 120 | 85 | 5 | MP:0009786 | |
| MousePheno | abnormal gland physiology | CCR10 TRAF2 PDE3B PSG1 PSG3 PSG4 OPRM1 HIPK3 PTPRF TK1 TMPRSS2 PSG8 | 9.24e-04 | 691 | 85 | 12 | MP:0002164 |
| MousePheno | increased circulating leptin level | 9.78e-04 | 125 | 85 | 5 | MP:0005669 | |
| MousePheno | increased total body fat amount | 1.07e-03 | 424 | 85 | 9 | MP:0010024 | |
| MousePheno | insulin resistance | 1.26e-03 | 197 | 85 | 6 | MP:0005331 | |
| MousePheno | placenta necrosis | 1.28e-03 | 9 | 85 | 2 | MP:0013247 | |
| MousePheno | small mandibular coronoid process | 1.28e-03 | 9 | 85 | 2 | MP:0030283 | |
| MousePheno | small mandibular condyloid process | 1.28e-03 | 9 | 85 | 2 | MP:0030258 | |
| Domain | ZINC_FINGER_C2H2_2 | ZXDC ZNF93 ZNF765 ZNF627 ZNF586 ZEB1 ZNF555 TRPS1 ZNF485 ZNF429 ZFP28 ZNF491 ZNF440 ZNF77 ZNF557 ZNF512B ZNF7 ZNF106 ZSCAN32 ZNF550 ZNF530 ZNF256 ZNF347 ZNF558 ZNF737 ZNF841 ZNF679 ZNF512 ZBTB3 ZNF583 ZNF669 | 3.38e-15 | 775 | 134 | 31 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZXDC ZNF93 ZNF765 ZNF627 ZNF586 ZEB1 ZNF555 TRPS1 ZNF485 ZNF429 ZFP28 ZNF491 ZNF440 ZNF77 ZNF557 ZNF512B ZNF7 ZNF106 ZSCAN32 ZNF550 ZNF530 ZNF256 ZNF347 ZNF558 ZNF737 ZNF841 ZNF679 ZNF512 ZBTB3 ZNF583 ZNF669 | 3.63e-15 | 777 | 134 | 31 | PS00028 |
| Domain | Znf_C2H2-like | ZXDC ZNF93 ZNF765 ZNF627 ZNF586 ZEB1 ZNF555 TRPS1 ZNF485 ZNF429 ZFP28 ZNF491 ZNF440 ZNF77 ZNF557 ZNF512B ZNF7 ZNF106 ZSCAN32 ZNF550 ZNF530 ZNF256 ZNF347 ZNF558 ZNF737 ZNF841 ZNF679 ZNF512 ZBTB3 ZNF583 ZNF669 | 7.00e-15 | 796 | 134 | 31 | IPR015880 |
| Domain | Znf_C2H2 | ZXDC ZNF93 ZNF765 ZNF627 ZNF586 ZEB1 ZNF555 TRPS1 ZNF485 ZNF429 ZFP28 ZNF491 ZNF440 ZNF77 ZNF557 ZNF512B ZNF7 ZNF106 ZSCAN32 ZNF550 ZNF530 ZNF256 ZNF347 ZNF558 ZNF737 ZNF841 ZNF679 ZNF512 ZBTB3 ZNF583 ZNF669 | 9.50e-15 | 805 | 134 | 31 | IPR007087 |
| Domain | ZnF_C2H2 | ZXDC ZNF93 ZNF765 ZNF627 ZNF586 ZEB1 ZNF555 TRPS1 ZNF485 ZNF429 ZFP28 ZNF491 ZNF440 ZNF77 ZNF557 ZNF512B ZNF7 ZNF106 ZSCAN32 ZNF550 ZNF530 ZNF256 ZNF347 ZNF558 ZNF737 ZNF841 ZNF679 ZNF512 ZBTB3 ZNF583 ZNF669 | 1.05e-14 | 808 | 134 | 31 | SM00355 |
| Domain | KRAB | ZNF93 ZNF765 ZNF627 ZNF586 ZNF555 ZNF485 ZNF429 ZFP28 ZNF440 ZNF77 ZNF557 ZNF7 ZSCAN32 ZNF550 ZNF530 ZNF256 ZNF347 ZNF558 ZNF737 ZNF679 ZNF583 ZNF669 | 1.10e-14 | 358 | 134 | 22 | PS50805 |
| Domain | KRAB | ZNF93 ZNF765 ZNF627 ZNF586 ZNF555 ZNF485 ZNF429 ZFP28 ZNF440 ZNF77 ZNF557 ZNF7 ZSCAN32 ZNF550 ZNF530 ZNF256 ZNF347 ZNF558 ZNF737 ZNF679 ZNF583 ZNF669 | 2.17e-14 | 370 | 134 | 22 | IPR001909 |
| Domain | zf-C2H2 | ZNF93 ZNF765 ZNF627 ZNF586 ZNF555 TRPS1 ZNF485 ZNF429 ZFP28 ZNF491 ZNF440 ZNF77 ZNF557 ZNF7 ZNF106 ZSCAN32 ZNF550 ZNF530 ZNF256 ZNF347 ZNF558 ZNF737 ZNF841 ZNF679 ZNF512 ZBTB3 ZNF583 ZNF669 | 7.17e-14 | 693 | 134 | 28 | PF00096 |
| Domain | KRAB | ZNF93 ZNF765 ZNF627 ZNF586 ZNF555 ZNF485 ZNF429 ZFP28 ZNF440 ZNF77 ZNF557 ZNF7 ZNF550 ZNF530 ZNF256 ZNF347 ZNF558 ZNF737 ZNF679 ZNF583 ZNF669 | 1.17e-13 | 358 | 134 | 21 | PF01352 |
| Domain | KRAB | ZNF93 ZNF765 ZNF627 ZNF586 ZNF555 ZNF485 ZNF429 ZFP28 ZNF440 ZNF77 ZNF557 ZNF7 ZNF550 ZNF530 ZNF256 ZNF347 ZNF558 ZNF737 ZNF679 ZNF583 ZNF669 | 2.11e-13 | 369 | 134 | 21 | SM00349 |
| Domain | - | ZXDC ZNF93 ZNF765 ZNF627 ZNF586 ZEB1 ZNF555 ZNF485 ZNF429 ZFP28 ZNF491 ZNF440 ZNF77 ZNF557 ZNF7 ZSCAN32 ZNF550 ZNF530 ZNF256 ZNF347 ZNF558 ZNF737 ZNF841 ZNF679 ZBTB3 ZNF583 ZNF669 | 3.13e-13 | 679 | 134 | 27 | 3.30.160.60 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZXDC ZNF93 ZNF765 ZNF627 ZNF586 ZEB1 ZNF555 ZNF485 ZNF429 ZFP28 ZNF491 ZNF440 ZNF77 ZNF557 ZNF7 ZSCAN32 ZNF550 ZNF530 ZNF256 ZNF347 ZNF558 ZNF737 ZNF841 ZNF679 ZBTB3 ZNF583 ZNF669 | 5.25e-13 | 694 | 134 | 27 | IPR013087 |
| Domain | zf-C2H2_6 | ZNF93 ZNF765 ZNF627 ZNF586 ZNF555 ZNF429 ZFP28 ZNF440 ZNF77 ZNF530 ZNF256 ZNF558 ZNF737 ZNF841 ZNF669 | 7.84e-09 | 314 | 134 | 15 | PF13912 |
| Domain | Olfact_rcpt | OR8K1 OR9A4 OR9G1 OR4C6 OR8S1 OR5A2 OR6F1 OR6A2 OR10K1 OR5K1 OR5H1 OR7G3 OR51B2 OR5AP2 OR9A2 | 1.51e-07 | 393 | 134 | 15 | IPR000725 |
| Domain | GPCR_Rhodpsn_7TM | OR8K1 CCR10 OR9A4 OR9G1 OR4C6 GPR39 OR8S1 OR5A2 OPRM1 OR6F1 OR6A2 OR10K1 CCR5 OR5K1 OR5H1 OR7G3 OR51B2 OR5AP2 OR9A2 | 3.18e-07 | 670 | 134 | 19 | IPR017452 |
| Domain | 7tm_1 | OR8K1 CCR10 OR9A4 OR9G1 OR4C6 GPR39 OR8S1 OR5A2 OPRM1 OR6F1 OR6A2 OR10K1 CCR5 OR5K1 OR5H1 OR7G3 OR51B2 OR5AP2 OR9A2 | 3.72e-07 | 677 | 134 | 19 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | OR8K1 CCR10 OR9A4 OR9G1 OR4C6 GPR39 OR8S1 OR5A2 OPRM1 OR6F1 OR6A2 OR10K1 CCR5 OR5K1 OR5H1 OR7G3 OR51B2 OR5AP2 OR9A2 | 4.45e-07 | 685 | 134 | 19 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | OR8K1 CCR10 OR9A4 OR9G1 OR4C6 GPR39 OR8S1 OR5A2 OPRM1 OR6F1 OR6A2 OR10K1 CCR5 OR5K1 OR5H1 OR7G3 OR51B2 OR5AP2 OR9A2 | 5.07e-07 | 691 | 134 | 19 | PS50262 |
| Domain | GPCR_Rhodpsn | OR8K1 CCR10 OR9A4 OR9G1 OR4C6 GPR39 OR8S1 OR5A2 OPRM1 OR6F1 OR6A2 OR10K1 CCR5 OR5K1 OR5H1 OR7G3 OR51B2 OR5AP2 OR9A2 | 5.19e-07 | 692 | 134 | 19 | IPR000276 |
| Domain | ZnF_TTF | 1.53e-04 | 3 | 134 | 2 | SM00597 | |
| Domain | Znf_TTF | 1.53e-04 | 3 | 134 | 2 | IPR006580 | |
| Domain | Ig_2 | 1.79e-04 | 73 | 134 | 5 | PF13895 | |
| Domain | Znf_MYM | 1.05e-03 | 7 | 134 | 2 | IPR010507 | |
| Domain | zf-FCS | 1.05e-03 | 7 | 134 | 2 | PF06467 | |
| Domain | TRASH_dom | 1.39e-03 | 8 | 134 | 2 | IPR011017 | |
| Domain | TRASH | 1.39e-03 | 8 | 134 | 2 | SM00746 | |
| Domain | Kringle-like | 1.54e-03 | 32 | 134 | 3 | IPR013806 | |
| Domain | IGc2 | 1.55e-03 | 235 | 134 | 7 | SM00408 | |
| Domain | Ig_sub2 | 1.55e-03 | 235 | 134 | 7 | IPR003598 | |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | OR8K1 OR9A4 OR9G1 OR4C6 OR8S1 OR5A2 OR6F1 OR6A2 OR10K1 OR5K1 OR5H1 OR7G3 OR51B2 OR5AP2 OR9A2 | 1.32e-07 | 417 | 96 | 15 | M4072 |
| Pathway | REACTOME_SENSORY_PERCEPTION | OR8K1 OR9A4 OR9G1 OR4C6 OR8S1 OR5A2 APOB OR6F1 OR6A2 OTOF OR10K1 OR5K1 OR5H1 OR7G3 OR51B2 OR5AP2 OR9A2 OTOG | 2.39e-07 | 636 | 96 | 18 | M41834 |
| Pathway | KEGG_OLFACTORY_TRANSDUCTION | OR8K1 OR9A4 OR9G1 OR4C6 OR8S1 OR5A2 OR6F1 OR6A2 OR10K1 OR5K1 OR7G3 OR51B2 OR5AP2 OR9A2 | 3.60e-07 | 389 | 96 | 14 | M14091 |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | ZNF627 ZNF586 ZNF555 ZNF485 ZNF429 ZFP28 ICE1 ZNF440 OPRM1 ZNF77 ZNF557 MED24 ZSCAN32 ZNF550 ZNF530 ZNF256 ZNF347 ZNF558 ZNF737 ZNF679 ANAPC7 ZNF583 ZNF669 | 4.23e-05 | 1387 | 96 | 23 | M734 |
| Pubmed | ZNF93 ZNF627 ZNF555 ZNF485 ZNF440 ZNF77 ZNF7 ZNF550 ZNF558 ZNF737 ZNF841 ZNF512 ZNF583 ZNF669 | 2.14e-14 | 181 | 139 | 14 | 37372979 | |
| Pubmed | Different evolutionary processes shaped the mouse and human olfactory receptor gene families. | OR8K1 OR9A4 OR9G1 OR4C6 OR8S1 OR5AK3P OR6F1 OR6A2 OR10K1 OR5K1 OR5H1 OR7G3 OR51B2 OR5AP2 OR9A2 | 8.56e-12 | 340 | 139 | 15 | 11875048 |
| Pubmed | OR8K1 OR9A4 OR9G1 OR4C6 OR8S1 OR5AK3P OR6F1 OR6A2 OR10K1 OR5K1 OR5H1 OR7G3 OR51B2 OR5AP2 OR9A2 | 8.56e-12 | 340 | 139 | 15 | 11802173 | |
| Pubmed | OR8K1 OR9A4 OR9G1 OR4C6 OR8S1 OR5AK3P OR6F1 OR6A2 OR10K1 OR5K1 OR5H1 OR7G3 OR51B2 OR5AP2 OR9A2 | 9.69e-12 | 343 | 139 | 15 | 32295537 | |
| Pubmed | OR8K1 OR9A4 OR9G1 OR4C6 OR8S1 OR5AK3P OR6F1 OR6A2 OR10K1 OR5K1 OR5H1 OR7G3 OR51B2 OR5AP2 OR9A2 | 1.10e-11 | 346 | 139 | 15 | 14611657 | |
| Pubmed | A mouse carcinoembryonic antigen gene family member is a calcium-dependent cell adhesion molecule. | 1.70e-07 | 13 | 139 | 4 | 1985902 | |
| Pubmed | CEACAM1+ myeloid cells control angiogenesis in inflammation. | 1.70e-07 | 13 | 139 | 4 | 19273835 | |
| Pubmed | Mechanism of glucose intolerance in mice with dominant negative mutation of CEACAM1. | 1.70e-07 | 13 | 139 | 4 | 16638824 | |
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 20044046 | ||
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 32150576 | ||
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 6265583 | ||
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 34440862 | ||
| Pubmed | CEACAM1 is a potent regulator of B cell receptor complex-induced activation. | 1.70e-07 | 13 | 139 | 4 | 12832451 | |
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 25406283 | ||
| Pubmed | Crystal structure of mouse coronavirus receptor-binding domain complexed with its murine receptor. | 1.70e-07 | 13 | 139 | 4 | 21670291 | |
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 22162753 | ||
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 2702644 | ||
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 8380065 | ||
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 1279194 | ||
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 25724769 | ||
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 26374765 | ||
| Pubmed | CEACAM1 deficiency delays important wound healing processes. | 1.70e-07 | 13 | 139 | 4 | 22092845 | |
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 11801635 | ||
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 28913658 | ||
| Pubmed | Expression of the Bgp gene and characterization of mouse colon biliary glycoprotein isoforms. | 1.70e-07 | 13 | 139 | 4 | 8500759 | |
| Pubmed | Mouse susceptibility to mouse hepatitis virus infection is linked to viral receptor genotype. | 1.70e-07 | 13 | 139 | 4 | 9343248 | |
| Pubmed | Ceacam1 deletion causes vascular alterations in large vessels. | 1.70e-07 | 13 | 139 | 4 | 23800882 | |
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 19285068 | ||
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 21760897 | ||
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 1719235 | ||
| Pubmed | Mouse hepatitis virus utilizes two carcinoembryonic antigens as alternative receptors. | 1.70e-07 | 13 | 139 | 4 | 1326665 | |
| Pubmed | Conditional deletion of CEACAM1 in hepatic stellate cells causes their activation. | 1.70e-07 | 13 | 139 | 4 | 39168268 | |
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 8402684 | ||
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 16619040 | ||
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 29377208 | ||
| Pubmed | Expression of MHV-A59 receptor glycoproteins in susceptible and resistant strains of mice. | 1.70e-07 | 13 | 139 | 4 | 8209741 | |
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 27002145 | ||
| Pubmed | Mice with null mutation of Ceacam I develop nonalcoholic steatohepatitis. | 1.70e-07 | 13 | 139 | 4 | 21949477 | |
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 26219866 | ||
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 2133556 | ||
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 32521208 | ||
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 19406938 | ||
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 19621080 | ||
| Pubmed | CEACAM1 promotes CD8+ T cell responses and improves control of a chronic viral infection. | 1.70e-07 | 13 | 139 | 4 | 29967450 | |
| Pubmed | Expression of newly identified secretory CEACAM1(a) isoforms in the intestinal epithelium. | 1.70e-07 | 13 | 139 | 4 | 19358828 | |
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 16680193 | ||
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 1653760 | ||
| Pubmed | Regulation of hepatic fibrosis by carcinoembryonic antigen-related cell adhesion molecule 1. | 1.70e-07 | 13 | 139 | 4 | 34058224 | |
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 10964771 | ||
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 32169849 | ||
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 22469976 | ||
| Pubmed | CEACAM1 creates a pro-angiogenic tumor microenvironment that supports tumor vessel maturation. | 1.70e-07 | 13 | 139 | 4 | 21532628 | |
| Pubmed | Structural and Molecular Evidence Suggesting Coronavirus-driven Evolution of Mouse Receptor. | 1.70e-07 | 13 | 139 | 4 | 28035001 | |
| Pubmed | Interaction between altered insulin and lipid metabolism in CEACAM1-inactive transgenic mice. | 1.70e-07 | 13 | 139 | 4 | 15316023 | |
| Pubmed | In vivo adaptation and persistence of Neisseria meningitidis within the nasopharyngeal mucosa. | 1.70e-07 | 13 | 139 | 4 | 23935487 | |
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 15331748 | ||
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 22673933 | ||
| Pubmed | Tumor angiogenesis mediated by myeloid cells is negatively regulated by CEACAM1. | 1.70e-07 | 13 | 139 | 4 | 22406619 | |
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 7628460 | ||
| Pubmed | Forced Hepatic Overexpression of CEACAM1 Curtails Diet-Induced Insulin Resistance. | 1.70e-07 | 13 | 139 | 4 | 25972571 | |
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 19008452 | ||
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 18544705 | ||
| Pubmed | Expression of the mouse hepatitis virus receptor by central nervous system microglia. | 1.70e-07 | 13 | 139 | 4 | 15220458 | |
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 18843289 | ||
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 15207636 | ||
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 21081647 | ||
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 11133662 | ||
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 11483763 | ||
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 2164599 | ||
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 29396368 | ||
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 18003729 | ||
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 26284027 | ||
| Pubmed | CEACAM1 specifically suppresses B cell receptor signaling-mediated activation. | 1.70e-07 | 13 | 139 | 4 | 33352461 | |
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 38381498 | ||
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 20739537 | ||
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 1633107 | ||
| Pubmed | The role of CEA-related cell adhesion molecule-1 (CEACAM1) in vascular homeostasis. | 1.70e-07 | 13 | 139 | 4 | 27695943 | |
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 20404914 | ||
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 26911181 | ||
| Pubmed | Hepatic CEACAM1 expression indicates donor liver quality and prevents early transplantation injury. | 1.70e-07 | 13 | 139 | 4 | 32027621 | |
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 30664851 | ||
| Pubmed | Role for hepatic CEACAM1 in regulating fatty acid metabolism along the adipocyte-hepatocyte axis. | 1.70e-07 | 13 | 139 | 4 | 27777319 | |
| Pubmed | 1.70e-07 | 13 | 139 | 4 | 18848945 | ||
| Pubmed | 2.37e-07 | 14 | 139 | 4 | 37531413 | ||
| Pubmed | Human CEACAM1-LF regulates lipid storage in HepG2 cells via fatty acid transporter CD36. | 2.37e-07 | 14 | 139 | 4 | 34666041 | |
| Pubmed | 2.37e-07 | 14 | 139 | 4 | 34619794 | ||
| Pubmed | SHP1 phosphatase-dependent T cell inhibition by CEACAM1 adhesion molecule isoforms. | 2.37e-07 | 14 | 139 | 4 | 17081782 | |
| Pubmed | Loss of Ceacam1 promotes prostate cancer progression in Pten haploinsufficient male mice. | 2.37e-07 | 14 | 139 | 4 | 32209360 | |
| Pubmed | 2.37e-07 | 14 | 139 | 4 | 11994468 | ||
| Pubmed | 2.37e-07 | 14 | 139 | 4 | 11850617 | ||
| Pubmed | 2.37e-07 | 14 | 139 | 4 | 20381490 | ||
| Pubmed | CEACAM1 regulates integrin αIIbβ3-mediated functions in platelets. | 2.37e-07 | 14 | 139 | 4 | 26196244 | |
| Pubmed | 2.37e-07 | 14 | 139 | 4 | 8896983 | ||
| Pubmed | 2.37e-07 | 14 | 139 | 4 | 22962327 | ||
| Pubmed | 2.37e-07 | 14 | 139 | 4 | 17623671 | ||
| Pubmed | 2.37e-07 | 14 | 139 | 4 | 26846848 | ||
| Pubmed | CEACAM1, a SOX9 direct transcriptional target identified in the colon epithelium. | 2.37e-07 | 14 | 139 | 4 | 18794798 | |
| Pubmed | 2.37e-07 | 14 | 139 | 4 | 23469261 | ||
| Pubmed | 2.37e-07 | 14 | 139 | 4 | 18454175 | ||
| Pubmed | 2.37e-07 | 14 | 139 | 4 | 22159884 | ||
| Interaction | PSG4 interactions | 1.00e-07 | 8 | 126 | 4 | int:PSG4 | |
| Interaction | GAGE12B interactions | 9.50e-07 | 4 | 126 | 3 | int:GAGE12B | |
| Interaction | GAGE12I interactions | 9.50e-07 | 4 | 126 | 3 | int:GAGE12I | |
| Interaction | PSG3 interactions | 9.77e-06 | 22 | 126 | 4 | int:PSG3 | |
| Interaction | SKIL interactions | 9.91e-06 | 119 | 126 | 7 | int:SKIL | |
| Interaction | GAGE5 interactions | 1.81e-05 | 52 | 126 | 5 | int:GAGE5 | |
| Interaction | MEGF8 interactions | 2.61e-05 | 56 | 126 | 5 | int:MEGF8 | |
| Interaction | FBLN5 interactions | 6.42e-05 | 159 | 126 | 7 | int:FBLN5 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | ZNF765 ZNF586 PSG1 PSG3 PSG4 PSG7 ZFP28 ELSPBP1 ZNF550 ZNF530 ZNF256 ZNF347 PSG8 ZNF841 ZNF583 | 3.66e-06 | 1192 | 139 | 15 | chr19q13 |
| Cytoband | 19q13.43 | 7.16e-06 | 87 | 139 | 5 | 19q13.43 | |
| Cytoband | 19p13.2 | 7.46e-05 | 229 | 139 | 6 | 19p13.2 | |
| Cytoband | 11q12.1 | 1.37e-04 | 161 | 139 | 5 | 11q12.1 | |
| Cytoband | 19q13.2 | 1.50e-04 | 164 | 139 | 5 | 19q13.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | ZNF627 ZNF555 ZNF491 ZNF440 NDUFA11 ZNF77 ZNF557 ZNF558 OR7G3 MAST3 | 1.68e-04 | 797 | 139 | 10 | chr19p13 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q12 | 6.70e-04 | 345 | 139 | 6 | chr11q12 | |
| Cytoband | 22q13.1 | 2.24e-03 | 85 | 139 | 3 | 22q13.1 | |
| Cytoband | 13q12 | 2.40e-03 | 24 | 139 | 2 | 13q12 | |
| Cytoband | 3q11.2 | 2.82e-03 | 26 | 139 | 2 | 3q11.2 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZXDC ZNF93 ZNF765 ZNF627 ZNF586 ZEB1 ZNF555 TRPS1 ZNF485 ZNF429 ZFP28 ZNF491 ZNF440 ZNF77 ZNF557 ZNF7 ZNF106 ZSCAN32 ZNF550 ZNF530 ZNF256 ZNF347 ZNF558 ZNF737 ZNF841 ZNF679 ZNF512 ZBTB3 ZNF583 ZNF669 | 8.24e-17 | 718 | 115 | 30 | 28 |
| GeneFamily | CD molecules|V-set domain containing|Pregnancy specific glycoproteins | 4.27e-09 | 11 | 115 | 5 | 1315 | |
| GeneFamily | Olfactory receptors, family 9 | 4.05e-04 | 23 | 115 | 3 | 156 | |
| GeneFamily | Zinc fingers MYM-type | 5.92e-04 | 6 | 115 | 2 | 86 | |
| GeneFamily | Olfactory receptors, family 5 | 7.45e-04 | 112 | 115 | 5 | 152 | |
| GeneFamily | CD molecules|C-C motif chemokine receptors | 1.75e-03 | 10 | 115 | 2 | 1091 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-07 | 196 | 136 | 8 | ab7be3858deabbd1fc44e8b9da8ff49a50bf1fb1 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.78e-06 | 187 | 136 | 7 | 35c382c0aabd46906113e5db30ea24bb8e658899 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.12e-06 | 192 | 136 | 7 | 28eb3a5728e8901bcb5ba12f6b009f41b065fa37 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.12e-06 | 192 | 136 | 7 | c0e59e642b42c055cf73d029cf54d07d9b719359 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.27e-06 | 194 | 136 | 7 | f76808666fb875fc787751cbfd924d9be20a8192 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.27e-06 | 194 | 136 | 7 | f5706ab6bc803606c4640ddd606617e4e797ccc9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.27e-06 | 194 | 136 | 7 | a52c5906fce43c2f72cf7e463a3d15cde06431f6 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.43e-06 | 196 | 136 | 7 | 8ad8efb631164b46f0c082572270188e5ead20bf | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.43e-06 | 196 | 136 | 7 | b8f89a50114932c08fc5daac4b549adfe9df8e66 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.43e-06 | 196 | 136 | 7 | 9606ea7e42f707e69ea891b3521037613b9675f5 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.43e-06 | 196 | 136 | 7 | 145fcf73deba9638b391a1af6c39fa205dc9829f | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.43e-06 | 196 | 136 | 7 | d0ff1082898d2db47c88d2678466514e9e9193d3 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.51e-06 | 197 | 136 | 7 | cd509e49bbdbf991cc5913960ff3ef275ad40628 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.51e-06 | 197 | 136 | 7 | 0f467ef58f0c4dcc00b34b7b9639e03fb3ebe780 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.51e-06 | 197 | 136 | 7 | 412cb5f37df57121ddd1492021445479c7cbccbf | |
| ToppCell | COVID-19-kidney-AQP1+PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 2.60e-06 | 198 | 136 | 7 | 8689090bce9ab6e8f122426a404037e572c6713b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.60e-06 | 198 | 136 | 7 | 0a172c6d997c7cfbad34b56e80121bd104dee67d | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D231|Adult / Lineage, Cell type, age group and donor | 1.26e-05 | 167 | 136 | 6 | 5af9127bae05768a5164d5708a4ad37edca99324 | |
| ToppCell | 356C-Myeloid-Dendritic-cDC1|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.44e-05 | 171 | 136 | 6 | 3d60e7ecf25e4b781ba2387671b2aad247fb75ff | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.54e-05 | 173 | 136 | 6 | 12f779b8dce79431b2d1002ba524dd3f9566aeb0 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.18e-05 | 184 | 136 | 6 | 688428103e8b19f45f2f65d70a0f30c904c8411c | |
| ToppCell | COVID-19-kidney-AQP1+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.77e-05 | 192 | 136 | 6 | 27ff3621e177e7932dd44dd6baa81551ea75a874 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.85e-05 | 193 | 136 | 6 | 52e918884877b6659cdca0496390e440f73694a9 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.29e-05 | 198 | 136 | 6 | 07701c73137947ed4a27e225975329235bbb8734 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.29e-05 | 198 | 136 | 6 | 31ba87552be97c9b78c9e82f98e96699ccb19824 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.29e-05 | 198 | 136 | 6 | 1378c6d4ceb84b42fdd6556be3296df7a8059e6e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.29e-05 | 198 | 136 | 6 | 451003a21162eeae90739fdb502bb50b362d80c8 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.29e-05 | 198 | 136 | 6 | 440af8f90c7afa1c07000806bcf9110b70f489fb | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.29e-05 | 198 | 136 | 6 | fa84bf8533d1b91d2c2bcf06b710670605072b89 | |
| ToppCell | COVID-19-kidney-Glomerular_EC|kidney / Disease (COVID-19 only), tissue and cell type | 3.39e-05 | 199 | 136 | 6 | fffd2f9042b55531dac4e5b463b5cee80402e7bb | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.48e-05 | 200 | 136 | 6 | b1be27d134a8633e3e7862c6a0d7be2001d387f0 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 5.93e-05 | 135 | 136 | 5 | 3351e8b9e417397c5fa9f856184ff24ce1a27242 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Peri/Epineurial_-NAF_endoneurial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 8.32e-05 | 145 | 136 | 5 | e808502fa52baf1c400f3c9b918a167127e78af9 | |
| ToppCell | COVID-19-kidney-Mito-rich_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.32e-05 | 145 | 136 | 5 | afed661aef990edb8e7012ab67ace56443520c9f | |
| ToppCell | 15-Trachea-Immune-Immune|Trachea / Age, Tissue, Lineage and Cell class | 8.59e-05 | 146 | 136 | 5 | ca722a89c6601e78f253d9484d01931f26161820 | |
| ToppCell | droplet-Liver-hepatocytes-3m-Epithelial-Hepatocyte_(Pericentral_and_Periportal)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.87e-05 | 147 | 136 | 5 | 00619115b9a1ec2b967c2992043b41974ece63c4 | |
| Computational | Neighborhood of CDKN1C | 8.43e-07 | 27 | 72 | 5 | GNF2_CDKN1C | |
| Computational | Neighborhood of EGFR | 2.05e-06 | 32 | 72 | 5 | GNF2_EGFR | |
| Computational | Neighborhood of IGFBP1 | 3.25e-06 | 35 | 72 | 5 | GNF2_IGFBP1 | |
| Computational | Neighborhood of MMP11 | 8.22e-06 | 42 | 72 | 5 | GNF2_MMP11 | |
| Computational | Neighborhood of TIMP2 | 1.30e-05 | 46 | 72 | 5 | GNF2_TIMP2 | |
| Computational | Neighborhood of KISS1 | 1.78e-05 | 49 | 72 | 5 | GNF2_KISS1 | |
| Disease | cD177 antigen measurement | 1.12e-06 | 18 | 132 | 4 | EFO_0021866 | |
| Disease | marginal zone B-cell lymphoma | 5.46e-04 | 8 | 132 | 2 | EFO_1000630 | |
| Disease | C-reactive protein measurement | SOX6 ZEB1 OR9G1 TRPS1 APOB CCDC168 USP44 ZNF106 PTPRF FAM227A SHE THNSL2 MAPK6 ZNF512 | 1.04e-03 | 1206 | 132 | 14 | EFO_0004458 |
| Disease | non-high density lipoprotein cholesterol measurement | 1.42e-03 | 713 | 132 | 10 | EFO_0005689 | |
| Disease | remnant cholesterol measurement | 1.43e-03 | 108 | 132 | 4 | EFO_0010815 | |
| Disease | colon carcinoma (is_marker_for) | 1.50e-03 | 13 | 132 | 2 | DOID:1520 (is_marker_for) | |
| Disease | gallbladder cancer (is_implicated_in) | 1.50e-03 | 13 | 132 | 2 | DOID:3121 (is_implicated_in) | |
| Disease | phospholipids in medium VLDL measurement | 1.65e-03 | 52 | 132 | 3 | EFO_0022154 | |
| Disease | cholesterol in small VLDL measurement | 1.74e-03 | 53 | 132 | 3 | EFO_0022228 | |
| Disease | bone density | 1.86e-03 | 388 | 132 | 7 | EFO_0003923 | |
| Disease | Hepatitis C | 2.01e-03 | 15 | 132 | 2 | C0019196 | |
| Disease | triglycerides in IDL measurement | 2.26e-03 | 58 | 132 | 3 | EFO_0022149 | |
| Disease | low density lipoprotein particle size measurement | 2.26e-03 | 58 | 132 | 3 | EFO_0008593 | |
| Disease | serum gamma-glutamyl transferase measurement | ZEB1 GPR39 SLCO1B3 ADAM30 SH3YL1 EYS TMPRSS2 FAM227A FLRT1 MAST3 ACSS3 | 2.74e-03 | 914 | 132 | 11 | EFO_0004532 |
| Disease | disease free survival | 2.90e-03 | 18 | 132 | 2 | EFO_0000409 | |
| Disease | total lipids in small VLDL | 3.40e-03 | 67 | 132 | 3 | EFO_0022148 | |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 4.06e-03 | 144 | 132 | 4 | EFO_0004611, EFO_0020943 | |
| Disease | vitamin D measurement | 4.11e-03 | 336 | 132 | 6 | EFO_0004631 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QYSCKGSELRHARSS | 106 | F5H4B4 | |
| ATCRTISGLYSASFH | 111 | P46092 | |
| ATKALLDASSRHCTY | 1821 | A6QL64 | |
| FTRSQKEGLHYTCSS | 166 | P51681 | |
| KYLGSCGRFLVSTST | 236 | Q9H7Y0 | |
| FSTVLSISHKSRYCG | 621 | Q9Y485 | |
| TIHFGSTSFKRAASA | 2156 | Q9C0F0 | |
| YESCSTAAFKHGRTE | 486 | P23786 | |
| FDSSGKLICSRTTGY | 461 | Q96IK5 | |
| TDCHRKAYSTTSIAS | 16 | Q86Y39 | |
| RISSSKGYLKAFSTC | 226 | Q8NH87 | |
| KGYLKAFSTCSSHLT | 231 | Q8NH87 | |
| LVFSSHCKAVSGYSD | 971 | Q9ULG1 | |
| SGCHSFYSKRYSRAL | 311 | Q9UJX3 | |
| VLTAAHCFKRYGNST | 671 | P56730 | |
| ARSCRFYSGSATLSK | 31 | Q96EY7 | |
| KYRQGSIDCTLTFSH | 211 | P35372 | |
| SKLCTSYSHSSTRDG | 31 | O95249 | |
| TSSYTLSCKLHTFLF | 101 | O43194 | |
| YVSCSHLRSKFGDLF | 936 | Q86YW9 | |
| HLRSKFGDLFSSACS | 941 | Q86YW9 | |
| SCKNGTTSTHLRGYF | 651 | Q5T1H1 | |
| TTSTHLRGYFFRKCV | 656 | Q5T1H1 | |
| SLRISCKGSGYSFTS | 36 | A0A0J9YXX1 | |
| TCSTSLLNGHFKVTY | 246 | P19827 | |
| LLCSKGSSFRYSGRT | 291 | Q6ZUT3 | |
| GGASYSLRRCLSSKS | 51 | Q8N6G6 | |
| KTSCALTIHAIGRYS | 1456 | Q5VYK3 | |
| GLYDKRSVHTLTSFC | 96 | P48058 | |
| SKLHVTLYNCSFGRS | 751 | O15031 | |
| SHTCNYKTRSSSYLD | 441 | Q16659 | |
| LFSFSYCKSHVITRA | 161 | Q9Y5P1 | |
| SATGRTKAFSTCASH | 231 | Q8NGI9 | |
| HGRIAYISSKSCSNP | 781 | Q13370 | |
| KSLCTFRGHESIIYS | 146 | O00628 | |
| RAVTNHSVYCSTKGA | 141 | Q7Z4W1 | |
| TALSCSSRHYAGRSF | 1816 | O94915 | |
| SGSRFCYLTDSHTSV | 141 | Q96EN8 | |
| ARSHIYTFASCSFSG | 736 | O15553 | |
| TFSEHLTSYICFLRK | 341 | Q6ZMI0 | |
| SLEGRHKAFSTCASY | 236 | Q8NGF4 | |
| GSASHVSKTVCSTYL | 346 | Q9H422 | |
| AKDTRYSSSFCTHDR | 56 | P04183 | |
| KAFSTCASHFLSVSL | 236 | Q8NHB7 | |
| ASVHTGFTFSLSFCK | 156 | Q8NH89 | |
| KAFSTCGAHLFSVSL | 236 | A6NKK0 | |
| ARNDTGYYTCSSSKH | 321 | P36888 | |
| SNCSYISFFKHISSG | 371 | Q9UKF2 | |
| TVYGNCSTHFTVKTR | 181 | P04114 | |
| TTDTTFSSAFCRKHG | 1066 | Q9Y2F5 | |
| RTGESSYRACFSFHS | 306 | Q96SD1 | |
| HSSYGLDSGFCTISR | 151 | Q00587 | |
| RTAAISGYSFKQCSH | 91 | P03951 | |
| TAGSCSHSFKRSFLE | 61 | O95236 | |
| QFSSCSHRFSKVYSS | 696 | O60307 | |
| VSEFCSYIKSSSSLG | 656 | Q69YH5 | |
| KGSVYFTCTHIHSLS | 36 | Q96BH3 | |
| KYTRVGKCSGHSSFI | 661 | O00423 | |
| LKSFYSEDSGSHCTR | 6831 | Q8NDH2 | |
| SSLCKATHTIGYGTT | 616 | Q9NZU1 | |
| TKHSGLYACSVRNSA | 386 | Q00888 | |
| SISLHGKGSFRFSYS | 261 | P02748 | |
| TKHSGLYVCSVRNSA | 386 | P11464 | |
| SKHRATCGIAQTYST | 1586 | Q9HC10 | |
| ATYTVRTFALHKSGS | 1486 | P10586 | |
| CAKTGYSASITFHTK | 591 | Q9BXB4 | |
| SASGRRKAFSTFASH | 226 | Q8NGT5 | |
| ASGRSKAFSTCSSHL | 231 | Q8NGZ6 | |
| AAGRYKAFSTCASHL | 236 | O95222 | |
| TKHSGLYACSVRNSA | 386 | Q16557 | |
| CQYILAKSRSSGTFT | 536 | Q6ZRI0 | |
| SVGRYKTFSTCASHL | 231 | Q8NGX5 | |
| YSSKGRHKALSTCSS | 226 | Q8NH72 | |
| YTITFCFSHLSGRLT | 26 | Q9HBX3 | |
| SSTPCLADKHFNYTS | 1746 | P11717 | |
| CLGKIGSYLSASTRH | 451 | Q96KG9 | |
| FGVYLSSGATHSSRK | 256 | Q8NG95 | |
| ISCKGQHSISYTLSR | 71 | Q9HAT8 | |
| TKHSGLYACSVRNSA | 386 | Q9UQ74 | |
| FDSSGKLVCSRTTGY | 461 | Q8NEA9 | |
| KEGRLSFYSGHSSFS | 161 | O14494 | |
| CALSSYSSHKGQAST | 816 | O75448 | |
| VALRSSAAVFTYCKS | 141 | Q96HL8 | |
| HGVTYAFKDLSLSCT | 106 | Q86YJ6 | |
| SRKGRYKAFSTCSSH | 236 | Q8NGG5 | |
| AYSSHSSTLLCFRDG | 2966 | Q9P2P6 | |
| TKHSGLYACSVRNSA | 386 | Q13046 | |
| TSGRSKAFSTCSAHL | 231 | Q8NH09 | |
| SALHFGSTVKYSCVG | 2396 | Q4LDE5 | |
| SSGRRKSFSTCASHF | 231 | Q8NGU2 | |
| YTSHRTASGCPLAAK | 831 | O60284 | |
| LCSLYSFRNTSTSPH | 86 | P35712 | |
| RKSFCTIHSTGYLKS | 276 | O00327 | |
| CRALSSGSGSEYKTH | 51 | Q9H6R3 | |
| HYSCRESTKLQTTGR | 401 | Q8N957 | |
| HRYCSFCLASILSSG | 51 | Q12933 | |
| FSCESSSSLKLLEHY | 441 | Q9UHF7 | |
| KQCGKSFSYSATHRI | 231 | Q8IYI8 | |
| ECGKAFKYSSTLSSH | 401 | P35789 | |
| DVCHKSFRYGSSLTV | 536 | Q8NHY6 | |
| CGKSFAYTSSLIKHR | 211 | Q9NXT0 | |
| KAFTCYSSLREHGRT | 331 | Q15935 | |
| YHSDACSSKAVVSLR | 226 | O15393 | |
| CGKAFSYSSTFRRHT | 261 | Q8NEP9 | |
| CARFSARSSLYIHSK | 426 | Q2QGD7 | |
| CGKTFSRSSYLVRHQ | 526 | Q9NX65 | |
| FTLGRHYSQDCSSIK | 591 | Q9P227 | |
| HYSQDCSSIKAGRRS | 596 | Q9P227 | |
| CGKSFTSNSYLSVHK | 381 | Q96NG5 | |
| ECGKSYRQSSSLITH | 271 | Q9Y2P7 | |
| CGKAFSLSSSLTYHK | 301 | Q8IYX0 | |
| SSSGIKKHTVFYNCS | 491 | Q9NPD5 | |
| CGKAFSRSSYFRIHE | 396 | Q7L945 | |
| LIHLSCYFSSGSCGK | 11 | O75310 | |
| DCSITDFRKSHTLSY | 551 | Q96AE7 | |
| CLGRFFLVYCSSSTH | 111 | O43543 | |
| PNCKKRFSHSGSYSS | 271 | P37275 | |
| CGKAFSVYSSLTTHQ | 546 | Q96SE7 | |
| SECGRTFSHKTSLVY | 596 | Q6ZN19 | |
| YSSVSGLKAHLASCS | 761 | Q96KM6 | |
| CGKAFSQSSTLIRHY | 236 | Q7Z398 | |
| TAYQRKGSAHLFCST | 256 | Q9UJ78 | |
| ECGKAFSRYSTLTTH | 261 | Q86V71 | |
| KAFTCSTSFQYHERT | 306 | Q8N8L2 | |
| CGKTFSRTSSLTYHH | 471 | Q7L2R6 | |
| SECGKSFSHSTNLYR | 326 | Q6P9A1 | |
| TCSSIGLHKTSLNAY | 591 | Q13395 | |
| KYFSCGRESFATHGT | 486 | Q5SVZ6 | |
| HRGATKSSGCSTYIN | 131 | Q5VZ18 | |
| CGKTFSSRSYLTVHK | 206 | Q8N988 | |
| GKAFGTRSSLSSHYS | 291 | Q8N988 | |
| CGKSFTNSFSLTIHR | 346 | Q8N988 | |
| YCQGKSFAATISRTT | 2126 | Q5T4S7 | |
| GSNYSLARHTCKALT | 1166 | Q9Y4E6 | |
| VYSSVSGLKAHLGSC | 416 | Q96ME7 | |
| CGKSFRYSSSFAGHQ | 331 | Q8NCK3 | |
| TGSSDHTIRCYNVKS | 1591 | Q9H2Y7 | |
| SGACKFIGSLHSYSF | 226 | Q8WY91 | |
| KSQNYHCTTRSGRFL | 106 | Q9H0E7 | |
| VCGKAFSYSGSLTLH | 496 | Q96ND8 | |
| CGKAFSRSSYLIEHQ | 586 | P17097 | |
| KAFSCSTSLRYHGSI | 341 | Q96BR6 | |
| LSSGCLSFSFHYILR | 281 | Q9Y493 | |
| TCGKTFSCSYTLRRH | 476 | Q9H5J0 | |
| CGRAFKYFSSLTTHK | 346 | O75373 | |
| ECGEAFKYSSSLTTH | 401 | O75373 | |
| SSVNEGSTYHKSCSF | 541 | O14974 |